Keller, A. K., Lassen, C. K., Møldrup, U.
, Bibby, B. M. & Jespersen, B. (2013).
Messengers of renal graft quality during warm and cold ischemia - a porcine microdialysis study.
Transplantation Proceedings,
45(3), 1172-7.
Bentzon, D. N.
, Borre, M., Ørntoft, T. F., Mortensen, M. M.
& Andersen, L. D. (2012).
Expression Profiling of Hereditary versus Sporadic Prostate Cancer Suggests CYR61, EGR3, KLF6 and SNF1LK as Differentially Expressed Genes.
Open Journal of Urology, 45-54.
Heidenreich, A., Witjes, W. P. J., Johansen, T. E. B., Patel, A. & EAU Research Foundation (2012).
Therapies used in prostate cancer patients by European urologists: data on indication with a focus on expectations, perceived barriers and guideline compliance related to the use of bisphosphonates.
Urologia Internationalis,
89(1), 30-8.
https://doi.org/10.1159/000338810
Borre, M. (2013).
Urologi. In H. R. Ivarsen & A. Aziz (Eds.),
Sygdomslære for sundhedsprofessionelle (1 ed., Vol. 1, pp. 127-142). Gads Forlag.
Pandha, H.
, Sørensen, K. D., Ørntoft, T. F., Langley, S., Hoyer, S.
, Borre, M. & Morgan, R. (2012).
Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer.
B J U International (Print),
110(6 Pt B), E287-92.
https://doi.org/10.1111/j.1464-410X.2012.11208.x
Keller, A. K., Jørgensen, T. M., Vittrup, D. M., Kjerkegaard, U. K.
, Jespersen, B., Krag, S. R. P.
, Bibby, B. M. & Stolle, L. B. (2013).
Fast Detection of Renal Ischemia in Transplanted Kidneys With Delayed Graft Function-An Experimental Study.
Transplantation,
95(2), 275-279.
https://doi.org/10.1097/TP.0b013e318276a1c8
Birkenkamp-Demtröder, K., Mansilla, F.
, Andersen, L. D., Thorsen, K., Fristrup, N., Brems-Eskildsen, A. S., Madsen, P. P.
, Sørensen, K. D., Borre, M. & Ørntoft, T. F. (2013).
TOX3 (TNRC9) overexpression in bladder cancer cells decreases cellular proliferation and triggers an interferon-like response.
Journal of Molecular Biomarkers & Diagnosis,
4(1), 1-11.
https://doi.org/10.4172/2155-9929.1000140
Sørensen, K. D., Abildgaard, M. O., Haldrup, C., Ulhøi, B. P., Kristensen, H.
, Strand, S. H., Parker, C., Høyer, S.
, Borre, M. & Ørntoft, T. F. (2013).
Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer.
B J C, (108), 420-428.
https://doi.org/10.1038/bjc.2012.549